ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,813, issued on July 14, was assigned to TANABE PHARMA Corp. (Osaka, Japan).

"Triazine compound salt, crystal form thereof, and production method therefor" was invented by Takafumi Yamagami (Osaka, Japan), Tomofumi Setsuta (Osaka, Japan), Yoshihiro Sugiura (Osaka, Japan) and Naoko Ueda (Osaka, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a salt of a triazine compound which has an inhibitory action against aldosterone synthase and is useful as a drug, and especially as a drug for preventing or treating primary aldosteronism and the like, a crystal thereof, and a method for producing the same. Specifically, the pr...